Development of an anti-core lipopolysaccharide vaccine for the prevention and treatment of sepsis
Development of an anti-core lipopolysaccharide vaccine for the prevention and treatment of sepsis
About this item
Full title
Author / Creator
Publisher
Oxford: Elsevier Ltd
Journal title
Language
English
Formats
Publication information
Publisher
Oxford: Elsevier Ltd
Subjects
More information
Scope and Contents
Contents
Sepsis continues to be a leading cause of death among hospitalized patients. Despite advances in supportive care and the availability of potent antimicrobials, the mortality exceeds 20%. The passive infusion of antibodies directed against a conserved region of the lipopolysaccharide (LPS) of Gram-negative bacteria was highly protective in an early...
Alternative Titles
Full title
Development of an anti-core lipopolysaccharide vaccine for the prevention and treatment of sepsis
Authors, Artists and Contributors
Author / Creator
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_71767160
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_71767160
Other Identifiers
ISSN
0264-410X
E-ISSN
1873-2518
DOI
10.1016/j.vaccine.2003.11.025
